A prospective cohort study to assess effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis
Latest Information Update: 27 Apr 2021
At a glance
- Drugs Bedaquiline (Primary) ; Clofazimine (Primary) ; Ethionamide (Primary) ; Levofloxacin (Primary) ; Linezolid (Primary) ; Pyrazinamide (Primary) ; Terizidone (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms PROBeX
- 27 Apr 2021 New trial record
- 12 Apr 2021 Results published in the Clinical Infectious Diseases